In this In Focus, we explore how organ-on-a-chip technology is being used to improve drug discovery and development.

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, and accelerating timelines.

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of ...

Cytochrome P450 (CYP) proteins are responsible for breaking down more than 80% of all Food and Drug Administration (FDA)-approved drugs, reducing their effectiveness. However, how to prevent CYPs ...

slashing years off the drug development process – allowing new drugs to reach patients faster. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological ...

This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma ...

“While targeting areas of unmet need inherently involves greater complexity and risk than incremental improvements on launched drugs and are more time consuming both in development and through ...

Spatial biomarkers are making their mark on oncology drug development. By quantifying the spatial heterogeneity ... for the human eye to calculate on their own.” AI’s ability to process complex ...